REG - Hipgnosis Songs Fund - Director/PDMR Shareholding

Hipgnosis Songs FundAnnouncement

14/08/2023 12:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230814:nRSN2547Ja&default-theme=true

RNS Number : 2547J  Hipgnosis Songs Fund Limited  14 August 2023

LEI: 213800XJIPNDVKXMOC11

14 August 2023

 

Hipgnosis Songs Fund Limited

("Hipgnosis" or the "Company")

 

Notification of Transactions of Persons Discharging Managerial
Responsibilities (PDMRs)

The Company announces that it has been advised that Andrew Sutch, a Director
of the Company, has acquired 1,071 ordinary shares in the Company ("Ordinary
Shares") following the automatic reinvestment of dividend proceeds. Following
this transaction, Mr Sutch holds a total of 65,996 Ordinary Shares, which
equates to 0.005% of the issued share capital.

Details of the transaction can be found in the Notification of Dealing Form
below.

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Andrew Sutch

 2    Reason for the notification
 a)   Position/status                                              Director

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Hipgnosis Songs Fund Limited

 b)   LEI                                                          213800XJIPNDVKXMOC11

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  HIPGNOSIS SONGS FUND LIMITED, ORDINARY SHARES

      Identification code

                                                                   GG00BFYT9H72
 b)   Nature of the transaction                                    Reinvestment of dividend proceeds

 c)   Price(s) and volume(s)                                       Price(s)                     Volume(s)

79.5009 pence

                                                                                                1,071
 d)   Aggregated information

      - Aggregated volume                                          1,071

      - Price                                                      79.5009 pence

      - Principal amount                                           £851.45

 e)   Date of the transaction                                      11 August 2023

 f)   Place of the transaction                                     London Stock Exchange, Main Market

 For more information:

 

For further information please contact:

 Hipgnosis Song Management

 Merck Mercuriadis

 Chris Helm

 Giles Croot (Media)                                            +44 (0)20 4542 1511

 Rufina Pavry (Investors)                                       +44 (0)20 4542 1530
 Singer Capital Markets - Joint Corporate Broker

 James Moat / James Maxwell / Alex Emslie (Corporate Finance)   +44 (0)20 7496 3000

 Alan Geeves / James Waterlow / Sam Greatrex (Sales)
 J.P. Morgan Cazenove - Joint Corporate Broker

 William Simmonds / Jérémie Birnbaum (Corporate Finance)        +44 (0)20 7742 4000

 James Bouverat (Sales)
 RBC Capital Markets - Joint Corporate Broker

 Elliot Thomas / Max Avison (Corporate Finance)                 +44 (0)20 7635 4000

 Lisa Tugwell / Natalia Lipecka (Sales)
 Ocorian - Company Secretary & Administrator

 Lorna Zimny                                                    +44 (0) 28 9693 0222
 The Outside Organisation

 Alan Edwards / Nick Caley                                      +44 (0)7711 081 843
 Headland Consultancy

 Susanna Voyle / Del Jones / Charlie Twigg                      +44 (0) 20 3805 4822
 All US music publicity enquiries

 Fran Defeo                                                     +1 917 767 5255

 Notes to Editors

 About Hipgnosis Songs Fund

 Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered
 investment company established to offer investors a pure-play exposure to
 songs and associated musical intellectual property rights. The Company has
 raised a total of almost £1.3 billion (gross equity capital) through its
 Initial Public Offering on 11 July 2018, and subsequent issues in April
 2019, August 2019, October 2019, July 2020, September 2020, February
 2021 and July 2021. In September 2019, Hipgnosis transferred its entire
 issued share capital to the Premium listing segment of the Official List of
 the FCA and to the London Stock Exchange's Premium segment of the Main
 Market, and in March 2020 became a constituent of the FTSE 250
 Index. Since April 2021, the Company has been resident in the UK for tax
 purposes and is recognised as an investment trust under applicable HMRC
 regulations.

 About Hipgnosis Song Management Limited

 The Hipgnosis Songs Fund's Investment Adviser is Hipgnosis Song Management
 Limited, which was founded by Merck Mercuriadis, former manager of globally
 successful recording artists, such as Elton John, Guns N' Roses, Morrissey,
 Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin
 Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The
 Investment Adviser has assembled an Advisory Board of highly successful
 music industry experts which include award winning members of the artist,
 songwriter, publishing, legal, financial, recorded music and music management
 communities, all with in-depth knowledge of music publishing. Members
 of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers,
 The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill
 Leibowitz, Ian Montone and Rodney Jerkins.

Notes to Editors

About Hipgnosis Songs Fund

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered
investment company established to offer investors a pure-play exposure to
songs and associated musical intellectual property rights. The Company has
raised a total of almost £1.3 billion (gross equity capital) through its
Initial Public Offering on 11 July 2018, and subsequent issues in April
2019, August 2019, October 2019, July 2020, September 2020, February
2021 and July 2021. In September 2019, Hipgnosis transferred its entire
issued share capital to the Premium listing segment of the Official List of
the FCA and to the London Stock Exchange's Premium segment of the Main
Market, and in March 2020 became a constituent of the FTSE 250
Index. Since April 2021, the Company has been resident in the UK for tax
purposes and is recognised as an investment trust under applicable HMRC
regulations.

 

About Hipgnosis Song Management Limited

 

The Hipgnosis Songs Fund's Investment Adviser is Hipgnosis Song Management
Limited, which was founded by Merck Mercuriadis, former manager of globally
successful recording artists, such as Elton John, Guns N' Roses, Morrissey,
Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin
Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The
Investment Adviser has assembled an Advisory Board of highly successful
music industry experts which include award winning members of the artist,
songwriter, publishing, legal, financial, recorded music and music management
communities, all with in-depth knowledge of music publishing. Members
of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers,
The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill
Leibowitz, Ian Montone and Rodney Jerkins.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBBGDIIDBDGXS